In Vitro Activity of Ceftazidime Combined with NXL104 versus Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals (CANWARD 2009 Study)

The in vitro activity of ceftazidime in combination with NXL104 versus 470 Pseudomonas aeruginosa clinical isolates was evaluated using Clinical and Laboratory Standards Institute (CLSI) broth microdilution methods. Ceftazidime had MIC(90)s of 8 μg/ml and 32 μg/ml in the presence and absence of NXL1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Walkty, A., DeCorby, M., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3101411/
https://ncbi.nlm.nih.gov/pubmed/21422208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01696-10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados